Sudden or Cardiac Deaths on Ibrutinib-Based Therapy were associated with a prior History of Hypertension or Cardiac Disease and the use of ACE-Inhibitors at Study Entry: Analysis from the Phase III NCRI FLAIR Trial
Munir, T. Pitchford, A. Bloor, A. Broom, A. Young, M. Kennedy, B. Walewska, R. Furtado, M. Preston, G. Neilson, J.
Munir, T.
Pitchford, A.
Bloor, A.
Broom, A.
Young, M.
Kennedy, B.
Walewska, R.
Furtado, M.
Preston, G.
Neilson, J.
Citations
Altmetric:
Abstract
Authors
Munir, T.
Pitchford, A.
Bloor, A.
Broom, A.
Young, M.
Kennedy, B.
Walewska, R.
Furtado, M.
Preston, G.
Neilson, J.
Pemberton, N.
Sidra, G.
Morley, N.
Cwynarski, K.
Schuh, A.
Forconi, F.
Gatto, S.
Paneesha, S.
Fox, C.
Howard, D.
Hockaday, A.
Cairns, D.
Jackson, S.
Greatorex, N.
Patten, P. E. M.
Allsup, D.
Hillmen, P.
Pitchford, A.
Bloor, A.
Broom, A.
Young, M.
Kennedy, B.
Walewska, R.
Furtado, M.
Preston, G.
Neilson, J.
Pemberton, N.
Sidra, G.
Morley, N.
Cwynarski, K.
Schuh, A.
Forconi, F.
Gatto, S.
Paneesha, S.
Fox, C.
Howard, D.
Hockaday, A.
Cairns, D.
Jackson, S.
Greatorex, N.
Patten, P. E. M.
Allsup, D.
Hillmen, P.
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Munir T, Pitchford A, Bloor A, Broom A, Young M, Kennedy B, et al. Sudden or Cardiac Deaths on Ibrutinib-Based Therapy were associated with a prior History of Hypertension or Cardiac Disease and the use of ACE-Inhibitors at Study Entry: Analysis from the Phase III NCRI FLAIR Trial. British Journal of Haematology. 2022;197:16-8.